Marshall Wace, LLP Becton Dickinson & CO Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Becton Dickinson & CO stock. As of the latest transaction made, Marshall Wace, LLP holds 57,181 shares of BDX stock, worth $13 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
57,181
Previous 784,439
92.71%
Holding current value
$13 Million
Previous $183 Million
92.48%
% of portfolio
0.02%
Previous 0.25%
Shares
25 transactions
Others Institutions Holding BDX
# of Institutions
1,738Shares Held
249MCall Options Held
690KPut Options Held
787K-
Vanguard Group Inc Valley Forge, PA26.6MShares$6.03 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5.05 Billion0.12% of portfolio
-
State Street Corp Boston, MA14MShares$3.17 Billion0.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13.6MShares$3.09 Billion0.38% of portfolio
-
Morgan Stanley New York, NY11MShares$2.49 Billion0.2% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $64.7B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...